DHC
Diversified Healthcare Trust
Real Estate · REIT - Healthcare Facilities · NMS
$8.53
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 85.7%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$2.1B
Total market value of the company
-18.97
Based on estimated future earnings — lower means cheaper
Rev Growth
-5.3%
Year-over-year revenue change
Profit Margin
-21.1%
How much profit the company keeps from each dollar of revenue
-17.9%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$8.95
+5% from current price — median analyst estimate
Recommendation
NONE
Consensus view from 4 analysts covering this stock
About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of September 30, 2025, DHC's approximately 6.7 billion US dollars portfolio included 335 properties in 34 states and Washington, D.C., with more than 26,000 senior living units, approximately 6.9 million square feet of medical office and life science properties and occupied by approximately 420 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with approximately 39 billion US dollars in assets under management as of September 30, 2025, and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. Diversified Healthcare Trust was incorporated in 1998 in Maryland, USA.

https://www.dhcreit.com

Country: United States Industry: REIT - Healthcare Facilities
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

MARKUP
Price trending up with increasing momentum
1.524
Excellent risk-adjusted returns
0.0699
Suggested allocation is meaningful — the edge justifies a position
1.896
Returns exceed worst-case losses — strong risk profile
Annual Return
97.0%
Historical annualised return based on price data
-51.2%
Largest peak-to-trough decline — the worst it has been
BULL
Statistical model sees bullish momentum
Days in State
23
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

2.32
Significantly more volatile than the market
52W High
$9.14
7% below the year high
52W Low
$3.07
178% above the year low
Avg Volume
1,834,711
Average daily shares traded — higher means easier to buy and sell
6.5
Days it would take all short sellers to cover — higher means more crowded
Short % Float
4.3%
Low short interest — limited bearish positioning
45.0%
Annual dividend as a percentage of the share price
$-1.33
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

149.23
Heavy leverage — higher financial risk if revenues decline
7.40
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
6.74
Like current ratio but excludes inventory — stricter test
Gross Margin
17.7%
Revenue left after cost of goods — higher means pricing power
Operating Margin
-1.3%
Profit from core operations before interest and tax
$248M
Positive — the business generates more cash than it spends
Revenue (TTM)
$1.5B
Total revenue over the last 12 months
Net Income
$-320,175,008
Loss-making — spending exceeds revenue after all costs
Analyst Coverage
Analysts
4
Target High
$10.00
Target Median
$8.95
Target Low
$6.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.